Well, I have to step in here and set a couple of things straight. The science of tissue fluorescence has been around awhile. The NIH, under the arm of the NIDCR (with insights starting much of this direction from previous director Dr. Hal Slavkin who is now dean of the USC School of Dentistry, and an OCF Advisory Board member, and current NIDCR leader Dr. Larry Tabak who I have met with on several occasions.) has put up the bulk of the money for looking at this science. Even the BC Cancer agency under Dr. Miriam Rosen (our newest advisory board member) who I just lectured with at the public health meeting in Denver this last week, got their funding from NIDCR. Some of the earliest work came out of multiple universities, again with the same funding source. The first working prototypes were made at the University of Texas, School of bioengineering. Those prototypes were tested by Dr's Ann Gillenwater and Rhonda Jacob at MDACC (Also friends of mine and with Jacob an OCF advisory board member). Gillenwater did proof of principle in the cervical area, and Jacob in the mouth, but they have consistently worked as a team. They are still working on the second-generation design, which is less a discovery device and more of a diagnostic device. This version is the VELscope on steroids. Since LED